Gilead GIO-Med 2019 Roadshow Manchester

An introduction to CAR-T in the UK

Thursday 12 & Friday 13 September 2019

Manchester Metropolitan University,
United Kingdom

This two-day meeting, Chaired by Professor John Snowden (Sheffield) on day 1 and Dr Sattva Neelapu (MD Anderson) on day 2 will feature a unique faculty of international experts presenting live in the room and being webcast out to other meetings around the UK.
On day 1 topics will include;
  • An overview of CAR-T therapy including the science behind the therapy.
  • An examination of UK patient selection guidelines.
  • Discussion and debate asking ‘Will CAR-T replace stem cell therapy?’
  • A review of primary mediastinal large B-cell lymphoma & national guidelines and finally...
  • A reality check… What about patients who can’t take CAR-T therapy?
On the 2nd day the meeting will consist of multiple workshop sessions designed to enable delegates to develop a deeper understanding of CAR-T therapy in the UK and the patient pathway from referral to treatment centres. 

Professor John Snowden
Consultant Haematologist,
Director of Blood and Marrow Transplantation,
Honorary Professor of Haemato-oncology & Stem Cell Transplantation,
Sheffield Teaching Hospitals NHS Foundation Trust , UK
Professor Sattva Neelapu
Professor, Department of Lymphoma/Myeloma,
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center, Houston, TX, USA


The full programme can be viewed HERE

Who should attend?
This meeting is ideal for:
  • Consultants
  • Pharmacists
  • Nurses
  • Researchers and
  • Scientists

and any healthcare professionals who have an interest in the future shape and direction of CAR-T therapy and research.


'An introduction to CAR-T in the UK - Manchester ' has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 9 category 1 (external) CPD credit(s) for attendance to BOTH DAYS (Single Day Attendance accounts for lower credits). Please note, CPD credits obtained through RCP will be accepted by other medical colleges such as the Royal College of Pathologists and the Royal College of Nursing.

When & Where
9:00 am - 3.30 pm Thursday, 12 September 2019

Manchester Metropolitan University
Business School Building
M15 6BH 
9:00 am - 2:30 pm Friday, 13 September 2019 
The Crowne Plaza
Oxford Road
M15 6PQ
Parking:  There are many public and private parking car parks around the Manchester Campus & Oxford Road.
Railway Station: Oxford Road Station is a 5 minute walk away from the Manchester Campus.

The Crowne Plaza - Oxford Road, Manchester.


The meeting costs are underwritten by Gilead Sciences Ltd. and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity. 

Date of preparation: July 2019  
This activity is intended for medical Haematology/Oncology healthcare professionals, scientists and academics involved in the management of, and research into CAR T-cell therapy in patients with high-grade lymphoid malignancies, specifically relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), as well as those with interest in the wider treatment landscape of haematological malignancies. Data on licensed CAR-T products will be presented.